368 related articles for article (PubMed ID: 37579878)
21. A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.
Amiral J; Laroche M; Seghatchian J
Transfus Apher Sci; 2018 Feb; 57(1):118-126. PubMed ID: 29525568
[TBL] [Abstract][Full Text] [Related]
22. On the role of coagulation and fibrinolysis in atherosclerosis.
Juhan-Vague I; Collen D
Ann Epidemiol; 1992 Jul; 2(4):427-38. PubMed ID: 1342293
[TBL] [Abstract][Full Text] [Related]
23. Fibrin Network Formation and Lysis in Septic Shock Patients.
Larsen JB; Aggerbeck MA; Larsen KM; Hvas CL; Hvas AM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502446
[TBL] [Abstract][Full Text] [Related]
24. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
25. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis.
Sidelmann JJ; Gram JB; Rasmussen JJ; Kistorp C
Semin Thromb Hemost; 2021 Feb; 47(1):11-17. PubMed ID: 33017849
[TBL] [Abstract][Full Text] [Related]
26. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
[TBL] [Abstract][Full Text] [Related]
27. THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
STAFFORD JL
J Clin Pathol; 1964 Sep; 17(5):520-30. PubMed ID: 14207786
[No Abstract] [Full Text] [Related]
28. Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango.
Fedorowski A; Siller-Matula JM; Patti G
Eur Heart J; 2022 Mar; 43(10):982-984. PubMed ID: 34686876
[No Abstract] [Full Text] [Related]
29. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
[TBL] [Abstract][Full Text] [Related]
30. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
31. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.
Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
Pharmacol Res; 2000 Jan; 41(1):81-4. PubMed ID: 10600273
[TBL] [Abstract][Full Text] [Related]
32. Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.
Vikerfors A; Svenungsson E; Ågren A; Mobarrez F; Bremme K; Holmström M; Eelde A; Bruzelius M; Elgue G; Wallén H; Antovic A
Thromb Res; 2014 May; 133(5):936-44. PubMed ID: 24630645
[TBL] [Abstract][Full Text] [Related]
33. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
Siudut J; Grela M; Wypasek E; Plens K; Undas A
J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
[TBL] [Abstract][Full Text] [Related]
34. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.
Weisel JW; Litvinov RI
Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):161-80. PubMed ID: 18673231
[TBL] [Abstract][Full Text] [Related]
35. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
Nogami K; Matsumoto T; Sasai K; Ogiwara K; Arai N; Shima M
Br J Haematol; 2019 Nov; 187(4):518-529. PubMed ID: 31335970
[TBL] [Abstract][Full Text] [Related]
36. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
[TBL] [Abstract][Full Text] [Related]
37. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
Aznar J; Estellés A; Bretó M; España F; Alós T
Thromb Res; 1992 Jun; 66(5):569-82. PubMed ID: 1387993
[TBL] [Abstract][Full Text] [Related]
38. Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.
Kearney KJ; Pechlivani N; King R; Tiede C; Phoenix F; Cheah R; Macrae FL; Simmons KJ; Manfield IW; Smith KA; Spurgeon BEJ; Naseem KM; Ariens RAS; McPherson MJ; Tomlinson DC; Ajjan RA
Blood; 2019 Mar; 133(11):1233-1244. PubMed ID: 30545831
[TBL] [Abstract][Full Text] [Related]
39. Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
Shen GX
Mol Cell Biochem; 2003 Apr; 246(1-2):69-74. PubMed ID: 12841345
[TBL] [Abstract][Full Text] [Related]
40. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
